Solaris Resources Inc. (CVE:SLS – Get Free Report) was down 2.7% on Friday . The company traded as low as C$5.95 and last traded at C$6.15. Approximately 53,313 shares were traded during mid-day trading, a decline of 60% from the average daily volume of 132,199 shares. The stock had previously closed at C$6.32.
Solaris Resources Stock Performance
The company has a 50-day moving average of C$6.15 and a two-hundred day moving average of C$6.15.
Solaris Resources (CVE:SLS – Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported C($0.18) earnings per share (EPS) for the quarter.
Solaris Resources Company Profile
SELLAS Life Sciences Group, Inc, a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer.
Featured Stories
- Five stocks we like better than Solaris Resources
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MP Materials: Rare Earth Elements Powering the EV Boom
- 5 Top Rated Dividend Stocks to Consider
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- What is a Special Dividend?
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Solaris Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solaris Resources and related companies with MarketBeat.com's FREE daily email newsletter.
